MRI and 2D-CSI MR spectroscopy of the brain in the evaluation of patients with acute onset of neuropsychiatric systemic lupus erythematosus

Neuroradiology

Volumn 47, Issue 8, 2005, Pages 576-585

  Sundgren, P C ^a   Jennings, J ^a   Attwood, J T ^a   Nan, B ^b   Gebarski, S ^a   McCune, W J ^a   Pang, Y ^a   Maly, P ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Brain; MRI; MRS; NP SLE; SLE; Spectroscopy

Indexed keywords

CHOLINE; CREATININE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; LACTIC ACID; LIPID; METHYLPREDNISOLONE; N ACETYLASPARTIC ACID; PHOSPHOLIPID ANTIBODY; PRASTERONE; PREDNISONE;

ADULT; ARTICLE; BRAIN SCINTISCANNING; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE DURATION; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; GRAY MATTER; HUMAN; IMAGE ANALYSIS; LABORATORY TEST; METABOLIC ENCEPHALOPATHY; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SJOEGREN SYNDROME; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT FAILURE; TREATMENT OUTCOME; WHITE MATTER;

ACUTE DISEASE; ADULT; BRAIN; BRAIN DISEASES; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; EPILEPSY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; PSYCHOTIC DISORDERS;

EID: 24344479566     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-005-1371-y     Document Type: Article

References (21)

1. Kovacs J, Urowitz M, Gladman D (1993) Dilemmas in neuropsychiatric lupus. Rheum Dis Clin North Am 19:795-819 1:STN:280:ByuD1cbpslQ%3D
2. Denburg S.D., Behmann S.A., Carbotte R.M., Denburg J.A. 1994 Lymphocyte antigens in neuropsychiatric systemic lupus erythematosus. Relationship of lymphocyte antibody specificities to clinical disease. Arthritis Rheum 37 369-375 1:STN:280:ByuC2srpvVE%3D
3. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature (1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42 599-608
4. Wasserman B.A., Stone J.H., Hellman D.B., Pomper M.G. 2001 Reliability of normal findings on MR imaging for excluding the diagnosis of vasculitis of the central nervous system. Am J Roentgenol 177 455-459 1:STN:280:DC%2BD3MvktVCqsQ%3D%3D
5. Jennings J.E., Sundgren P.C., Attwood J., McCune J., Maly P. 2004 Value of brain MRI in SLE patients presenting with neurologic symptoms. Neuroradiology 46 15-21 1:STN:280:DC%2BD2c%2Fls1ymsQ%3D%3D
6. Pomper M, Miller T, Stone J, Tidmore W, Hellman D (1999) CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography. Am J Neuroradiol 20:75-85 1:STN:280:DyaK1M7jvFKnsg%3D%3D
7. McCune J, MacGuire A, Aisen A, Gebarski S 1988 Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. Arthritis Rheum 31 159-166 1:STN:280:BieC283ptlw%3D
8. Jacobs L., Kinkel P., Costello P.B., Alukal M.K., Kinkel W.R., Green F.A. 1988 Central nervous system lupus erythematosus: The value of magnetic resonance imaging. J Rheumatol 15 601-606 1:STN:280:BieB1cnlvVY%3D
9. Sibbitt Jr. W.L., Sibbitt R.R., Griffey R.H., Eckel C., Bankhurst A.D. 1989 Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis 12 1014-1022
10. Lim M.K., Suh C.H., Kim H.J., Cho Y.K., Choi S.H., Kang J.H., Park W., Lee J.H. 2000 Systemic lupus erythematosus: Brain MR imaging and single-voxel hydrogen1 MR spectroscopy. Radiology 217 43-49 1:CAS:528:DC%2BD3cXnt12rtb4%3D
11. 1H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus. Ann Rheum Dis 60 106-111 1:STN:280:DC%2BD3M7is1Sqsg%3D%3D
12. Sibbitt Jr. W.L., Haseler L.J., Griffey R.R., Friedman S.D., Brooks W.M. 1997 Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopy. Am J Neuroradiol 18 1271-1277 9282854
13. Brooks W.M., Sabet A., Sibbitt Jr. W.L., Barker P.B., van Zijl P.C.M., Duyn J.H., Moonen C.T.W. 1997 Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus J Rheumatol 24 2323-2329 1:CAS:528:DyaK2sXnvFOit7g%3D
14. Chinn R.J.S., Wilkinson I.D., Hall-Craggs M.A., Paley M.N.J., Shorthall E., Carter S., Kendall B.E., Issenburg D.A., Newman S.P., Harrison M.J.G. 1997 Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. Arthritis Rheum 40 36-46 1:STN:280:ByiC287jsVU%3D
15. Friedman S.D., Stidley C.A., Brooks W.M., Hart B.L., Sibbitt Jr. W.L. 1998 Brain injury and neurometabolic abnormalities in systemic lupus erythematosus. Radiology 209 79-84 1:STN:280:DyaK1cvktF2msA%3D%3D
16. Provenzale J.M., Barboriak D.P., Allen N.B., Ortel T.L. 1996 Patients with antiphospholipid antibodies: CT and MR findings of the brain Am J Roentgenol 167 1573-1578 1:STN:280:ByiC3MrhvF0%3D
17. Provenzale J.M., Barboriak D.P., Allen N.B., Ortel T.L. 1998 Antiphospholipid antibodies: Findings at arteriography Am J Neuroradiol 19 611-616 1:STN:280:DyaK1c3js1Wrsw%3D%3D
18. Karassa F.B., Ioannidis J.P., Boki K.A. et al. 2000 Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus Am J Med 109 628-634 1:STN:280:DC%2BD3M%2FltVansA%3D%3D
19. Sabet A., Sibbitt Jr. W.M., Stidley C.A., Danska J., Brooks W.M. 1998 Neurometabolite markers of cerebral injury in the antiphospolipid antibody syndrome of systemic lupus erythematosus. Stroke 29 2254-2260 1:STN:280:DyaK1M%2FitFOrtg%3D%3D
20. Manthorpe R, Manthorpe T, Sjoberg S 1992 Magnetic resonance imaging of the brain in patients with primary Sjogrens's syndrome Scand J Rheumatol 21 148-149 1:STN:280:By2B1MvnvF0%3D
21. Provencher S.W. 1993 Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Mag Reson Med 30 6 672-679 1:CAS:528:DyaK2cXis1Gjtr0%3D